174 related articles for article (PubMed ID: 24955525)
1. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
[TBL] [Abstract][Full Text] [Related]
3. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
[TBL] [Abstract][Full Text] [Related]
4. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.
Zhang J; Zhou J; Tang X; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Qian J; Deng ZQ
Oncotarget; 2017 Nov; 8(54):92536-92544. PubMed ID: 29190935
[TBL] [Abstract][Full Text] [Related]
6. BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.
Zhou JD; Yang J; Guo H; Deng ZQ; Wen XM; Yang L; Yin JY; Xiao GF; Lin J; Qian J
Leuk Lymphoma; 2016; 57(4):828-34. PubMed ID: 26325005
[TBL] [Abstract][Full Text] [Related]
7. Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.
Zhou LY; Zhai LL; Yin JY; Vanessa ME; Zhou J; Zhang J; Tang X; Lin J; Qian J; Deng ZQ
Oncotarget; 2016 Jul; 7(30):47376-47386. PubMed ID: 27329719
[TBL] [Abstract][Full Text] [Related]
8. Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.
Guo H; Lin J; Wen XM; Yang J; Qian W; Deng ZQ; Ma JC; Tang CY; An C; Liu Q; Zhou H; Qian J
Int J Clin Exp Pathol; 2014; 7(8):4695-703. PubMed ID: 25197341
[TBL] [Abstract][Full Text] [Related]
9. [Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].
Yu MX; Lu Y; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):544-8. PubMed ID: 24078567
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
11. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.
Zhou JD; Wen XM; Zhang YY; Yang L; Ma YJ; Ma JC; Yang J; Guo H; Yao DM; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(3):2384-91. PubMed ID: 26045745
[TBL] [Abstract][Full Text] [Related]
14. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
15. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics.
Zhang TJ; Zhou JD; Ma JC; Deng ZQ; Qian Z; Yao DM; Yang J; Li XX; Lin J; Qian J
Clin Chem Lab Med; 2017 Jan; 55(1):123-131. PubMed ID: 27305704
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
[TBL] [Abstract][Full Text] [Related]
17. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of PDLIM4 gene correlates with good prognosis in acute myeloid leukemia.
Li Y; Qian J; Lin J; Qian W; Yang J; Chai HY; Wang CZ; Deng ZQ; Yao DM; Chen Q; Ma JC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1111-5. PubMed ID: 24156416
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
[TBL] [Abstract][Full Text] [Related]
20. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
